Objectives: The present study was conducted to determine the safety of the transcatheter
closure of a patent foramen ovale (PFO) in patients with cryptogenic cerebral ischemia and …

Objectives: The purpose of this study was to evaluate the efficacy and safety of device
closure of patent foramen ovale (PFO) versus antiplatelet therapy in patients with …

Paradoxical embolism through a patent foramen ovale (PFO) has been recognized as a
potential cause of transient ischemia attack (TIA) and stroke especially in younger patients …

Objectives: This study sought to examine the frequency of indications for and the immediate
and long-term clinical outcomes of transcatheter closure of patent foramen ovale (PFO) …

Aims Percutaneous patent foramen ovale (PFO) closure for secondary stroke prevention is
discussed controversially. Long-term data comparing different closure devices are limited …

Objectives: The purpose of this study was to compare the efficacy of medical treatment with
percutaneous closure of patent foramen ovale (PFO). Background: Patients with cryptogenic …

Background Patent foramen ovale (PFO) closure is the gold standard for treating patients
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …

Introduction—Patent foramen ovale (PFO) has been identified as a source of paradoxical
embolism and cryptogenic stroke. Low recurrence rates of ischaemic stroke after …

Methods Patients. Since January 1998, 35 patients have undergone percutaneous PFO
closure. In all cases, patient history included a thromboembolic event attributed to …

Background The comparative effectiveness of percutaneous closure of patent foramen ovale
(PFO) plus medical therapy versus medical therapy alone for cryptogenic stroke is uncertain …